Multihance Versus Magnevist in Breast MRI

Status:
Completed

Trial end date:
2009-12-01

Target enrollment:

Participant gender:

To show if one MRI contrast agent is better than another one in the diagnosis of malignant breast lesions compared to histopathology

Phase 3

Bracco Diagnostics, Inc